Entera Bio Ltd (NQ: ENTX )

1.360 USD -0.180 (-11.69%)

Official Closing Price Updated: 4:00 PM EST, Mar 4, 2021 Add to My Watchlist

Price and Volume

Volume	175,865
Open	1.520
Bid (Size)	1.350 (20)
Ask (Size)	1.400 (3)
Prev. Close	1.540
Today's Range	1.330 - 1.600
52wk Range	1.000 - 3.350
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Entera Bio To Present At The H.C. Wainwright Global Life Sciences Conference

Today 8:30 EST

Entera Bio Announces Publication of Phase 2 Hypoparathyroidism Study in the Journal of Bone and Mineral Research

February 25, 2021

Performance

YTD	+9.68%	+9.68%
1 Month	-2.86%	-2.86%
3 Month	+18.26%	+18.26%
6 Month	+22.52%	+22.52%
1 Year	-56.83%	-56.83%

More News

Entera Bio Initiates New Research Program For Oral GLP-2

February 08, 2021

Entera Bio Issues Letter to Shareholders

January 11, 2021

Entera Bio Announces FDA Approval of IND Application for EB613 – an Oral Human Parathyroid Hormone (1-34) for the Treatment of Osteoporosis

December 10, 2020

Entera Bio Appoints Spiros Jamas as Chief Executive Officer

November 30, 2020

Entera Bio Ltd Announces Third Quarter 2020 Financial Results and Provides Clinical Update

November 19, 2020

Entera Bio to Report Third Quarter 2020 Business and Financial Results on November 19, 2020

November 13, 2020

Entera Bio Ltd Announces Completion of Enrollment In Phase 2 Clinical Trial of Eb613 In Osteoporosis

November 09, 2020

Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference

November 02, 2020

Entera Bio to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

September 10, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.